Publication | Closed Access

Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats

InflammationMetabolic SyndromeMedicineMicrovascular DysfunctionPhysiologyDiabetesEndothelial DysfunctionVascular BiologyDiabetes MellitusHindlimb VasculatureFour-week AdministrationPharmacologyAtherosclerosisOxidative StressHealth Sciences